Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized double-blind dose-ranging placebo-controlled trial of Huangzhi Capsule for influenza (wind-heat invading Wei syndrome)
CTR20242250Phase 2Active
- Sponsor
- Sichuan Academy of Chinese Medical Sciences
- Start
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of huangzhi in influenza, sponsored by Sichuan Academy of Chinese Medical Sciences. Started Dec 2024; status: active.
02
Drugs
huangzhi
03
Conditions
influenza
Beyond the preview
Go deeper on CTR20242250.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20242250.